Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Lux

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|August 16, 2011
Impact of differential glycosylation on IgG activityAnja Lux, Falk Nimmerjahn
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2014
LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infectionFalk Nimmerjahn, Anja Lux
Journal of Clinical Immunology|September 6, 2012
Of mice and men: the need for humanized mouse models to study human IgG activity in vivoAnja Lux, Falk Nimmerjahn
Cancer Cell|January 14, 2015
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancerAnja Lux, Falk Nimmerjahn
Nature Reviews. Immunology|April 26, 2014
Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientistInessa Schwab, Anja Lux, Falk Nimmerjahn
Advances in Immunology|September 2, 2014
How immunoglobulin G antibodies kill target cells: revisiting an old paradigmMarkus Biburger, Anja Lux, Falk Nimmerjahn
Cell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk Nimmerjahn
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2023
Phenotyping of Macrophages in Human Immune System MiceLeonie Voss, Carmen Reitinger, Anja Lux
Trends in Immunology|May 19, 2015
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activitiesFalk Nimmerjahn, Sina Gordan, Anja Lux
Seminars in Immunopathology|April 30, 2014
Targeting B cells and autoantibodies in the therapy of autoimmune diseasesDaniela Kao, Anja Lux, Inessa Schwab, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|August 16, 2011
Impact of differential glycosylation on IgG activityAnja Lux, Falk Nimmerjahn
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2014
LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infectionFalk Nimmerjahn, Anja Lux
Journal of Clinical Immunology|September 6, 2012
Of mice and men: the need for humanized mouse models to study human IgG activity in vivoAnja Lux, Falk Nimmerjahn
Cancer Cell|January 14, 2015
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancerAnja Lux, Falk Nimmerjahn
Nature Reviews. Immunology|April 26, 2014
Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientistInessa Schwab, Anja Lux, Falk Nimmerjahn
Advances in Immunology|September 2, 2014
How immunoglobulin G antibodies kill target cells: revisiting an old paradigmMarkus Biburger, Anja Lux, Falk Nimmerjahn
Cell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk Nimmerjahn
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2023
Phenotyping of Macrophages in Human Immune System MiceLeonie Voss, Carmen Reitinger, Anja Lux
Trends in Immunology|May 19, 2015
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activitiesFalk Nimmerjahn, Sina Gordan, Anja Lux
Seminars in Immunopathology|April 30, 2014
Targeting B cells and autoantibodies in the therapy of autoimmune diseasesDaniela Kao, Anja Lux, Inessa Schwab, et al.
Pageof 7